NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 82 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $103,304 | -18.3% | 32,691 | 0.0% | 0.00% | – |
Q2 2023 | $126,514 | +10.3% | 32,691 | -21.0% | 0.00% | – |
Q1 2023 | $114,670 | +223.8% | 41,397 | +110.4% | 0.00% | – |
Q4 2022 | $35,417 | -13.6% | 19,676 | +1.6% | 0.00% | – |
Q3 2022 | $41,000 | -32.8% | 19,358 | -14.1% | 0.00% | – |
Q2 2022 | $61,000 | – | 22,536 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madrona Venture Group, LLC | 6,020,770 | $30,663,000 | 4.08% |
Ally Bridge Group (NY) LLC | 1,500,000 | $9,210,000 | 2.71% |
AMAZON COM INC | 1,457,055 | $8,946,000 | 1.82% |
Affinity Asset Advisors, LLC | 975,000 | $5,987,000 | 1.51% |
Tikvah Management LLC | 708,540 | $4,350,436,000 | 1.18% |
Perceptive Advisors | 8,911,151 | $54,714,000 | 0.80% |
Bain Capital Life Sciences Investors, LLC | 2,000,000 | $12,280,000 | 0.76% |
HILLMAN CO | 200,000 | $1,228,000 | 0.43% |
SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $4,912,000 | 0.41% |
RA Capital Management | 2,436,430 | $14,960,000 | 0.21% |